Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
22.80
-1.19 (-4.96%)
At close: Apr 28, 2026, 4:00 PM EDT
23.12
+0.32 (1.40%)
Pre-market: Apr 29, 2026, 6:16 AM EDT
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $315.88 million as of April 29, 2026. Its market cap has increased by 143.73% in one year.
Market Cap
315.88M
Enterprise Value
312.08M
1-Year Change
143.73%
Ranking
Category
Stock Price
$22.80
Market Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $315.88M, an increase of 359.88%. That is a compound annual growth rate of 31.37%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Monopar Therapeutics | 356.02M |
| Palisade Bio | 348.24M |
| Ovid Therapeutics | 342.87M |
| DiaMedica Therapeutics | 341.08M |
| Bicycle Therapeutics | 337.38M |
| Nautilus Biotechnology | 331.60M |
| Cabaletta Bio | 328.40M |
| Surrozen | 323.24M |